The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) concerning whether the board breached its fiduciary duties to shareholders.

If you are a shareholder, click here to participate.

On October 23, 2025, before the market opened, Integer reduced its full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion, below prior expectations, and informed investors that it anticipated net sales growth of –2% to 2% and organic sales growth of 0% to 4% for 2026. During the accompanying earnings call, management revealed that sales of three new products were expected to decline in 2026—including two electrophysiology devices—and that market adoption of these products had been slower than forecasted. The Company further stated that Cardio & Vascular sales growth was expected to decelerate due to declines in those electrophysiology products, with the impact continuing into 2026.

On this news, Integer’s stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share on October 23, 2025, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you still hold Integer shares purchased before July 2024 and wish to discuss this matter with us, or have any questions concerning your rights and interests with regards to this matter, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260226500174/en/